Search Results
11 Results for 'Autoimmune disorders'
PAGE 1 OF 1
Technology
Synthetic Protein For Inducing Immune Tolerance
The present invention from UW Madison researchers is a fusion protein made of the full length PDL-1 transmembrane protein and full length IDO cytosolic protein which the inventors termed PIDO. These t...
Learn More
Learn More
Jacques Galipeau, Pradyut Paul | P200100US02
Technology
METHOD TO INHIBIT NEUTROPHIL RECRUITMENT TO DAMAGED TISSUE USING MYELOID-DERIVED GROWTH FACTOR
A method to inhibit neutrophil recruitment to damaged tissue, thereby inhibiting inflammation in a subject. The method includes administering to an anti-inflammatory amount of a myeloid-derived growth...
Learn More
Learn More
Anna Huttenlocher, Deane Mosher, Valeriu Bortnov, David Bennin, Frances Smith, Ruth Houseright | P210066US02
Technology
Peptide-Nanoparticle Conjugates
Described herein is a nanoparticle system including a multivalent nanoparticle core having a plurality of β-hairpin peptides conjugated thereto. Also included are pharmaceutical compositions and meth...
Learn More
Learn More
Seungpyo Hong, Woo-jin Jeong | P200080US02
Technology
Novel Aryl Hydrocarbon Receptor Ligands Derived From Kynurenine
The present invention relates to novel compounds which are aryl hydrocarbon receptor (AHR) ligands and uses thereof. Methods of activating the AHR receptor in a subject are also provided. The compound...
Learn More
Learn More
Yongna Xing, Seunghyeon Seok, Zhi-Xiong Ma, John Feltenberger | P170316US02
Technology
Genetically Modified Genes And Cells, And Methods Of Using Same For Silencing Virus Gene Expression
Genetically modified CCNT1 and XPO1 genes encoding proteins that inhibit virus infection in cells. The genetically modified CCNT1 gene encodes a protein with a C261Y substitution with respect to the h...
Learn More
Learn More
Nathan Sherer, Ryan Behrens | P180284US02
Technology
Use of Salate Derivatives to Treat Multiple Sclerosis
Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease affecting 2.5 million people worldwide. The disease is difficult to manage and there is no cure. The underlying mechanism of MS pro...
Learn More
Learn More
Hector DeLuca, Lori Plum, Steven Marling, Yanping Wang | P160384US02
Technology
Vitamin D Analogs “1D-QM” and “1D-QMS” for Cancer, Bone Disease Therapy
The hormonally active form of vitamin D, known as calcitriol or 1,25 dihydroxyvitamin D3, has shown promise for treating diseases ranging from osteoporosis to cancer to psoriasis. However, the hormone...
Learn More
Learn More
Hector DeLuca, Lori Plum, Rafal Sicinski, Izabela Sibilska-Kaminski | P120085US02
Technology
Vitamin D Analogs “3D-QM” and “3D-QMS” for Treating Cancer and Bone Diseases
The hormonally active form of vitamin D, known as calcitriol or 1,25 dihydroxyvitamin D3, has shown promise for treating diseases ranging from osteoporosis to cancer to psoriasis. However, the hormone...
Learn More
Learn More
Hector DeLuca, Lori Plum, Rafal Sicinski, Izabela Sibilska-Kaminski | P120087US02
Technology
Vitamin D Analogs for Treating Bone Cancers and Diseases
The hormonally active form of vitamin D, known as calcitriol or 1,25 dihydroxyvitamin D3, has shown promise for treating diseases ranging from osteoporosis to cancer to psoriasis. However, the hormone...
Learn More
Learn More
Hector DeLuca, Margaret Clagett-Dame, Lori Plum, Izabela Sibilska-Kaminski, Rafal Sicinski | P100358US03
Technology
Vitamin D Analog “DA2HE” to Treat and Prevent Polyps, Hyperplastic Intestinal Disorders
The hormonally active form of vitamin D, known as calcitriol or 1,25 dihydroxyvitamin D3, has shown promise for treating diseases ranging from osteoporosis to cancer to psoriasis. However, the hormone...
Learn More
Learn More
Hector DeLuca, Margaret Clagett-Dame, Lori Plum, Agnieszka Glebocka | P120347US02
Technology
Novel Tautomycetin Analogs Provide Potential Natural Products for the Treatment of Cancer or Autoimmune Disease
Tautomycetin (TTN) is a complex polyketide natural product produced by Streptomyces griseochromogens. It specifically inhibits the protein phosphatases PP1 and PP2A, which are two of the four major s...
Learn More
Learn More
Ben Shen | P100341US02